Virginia Retirement Systems Et Al Editas Medicine, Inc. Transaction History

Virginia Retirement Systems Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 11, 2023	SELL	$7.03 - $11.53 $17,575 - $28,825	-2,500 Reduced 14.2%	15,100 $109,000
Q4 2022 May 17, 2023	BUY	$8.32 - $13.21 $39,936 - $63,408	4,800 Added 37.5%	17,600 $156 Million
Q3 2022 May 16, 2023	SELL	$12.16 - $19.42 $3,648 - $5,826	-300 Reduced 2.29%	12,800 $157 Million
Q1 2022 Apr 21, 2022	SELL	$14.08 - $27.63 $52,096 - $102,231	-3,700 Reduced 22.02%	13,100 $249,000
Q3 2021 Oct 21, 2021	BUY	$39.27 - $72.94 $3,927 - $7,294	100 Added 0.6%	16,800 $690,000
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $78,225 - $141,600	-2,500 Reduced 13.02%	16,700 $946,000
Q1 2021 Apr 30, 2021	BUY	$39.71 - $90.58 $67,507 - $153,986	1,700 Added 9.71%	19,200 $806,000
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $2,707 - $8,435	100 Added 0.57%	17,500 $1.23 Million
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $488,244 - $646,583	17,400 New	17,400 $488,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $87.3M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.